26th August, 2022

Pedanius Therapeutics receives Stage I support from INCATE

Read on

29th January, 2021

Pedanius Therapeutics shortlisted for the Bionow "AMR" Award 2020

Read on

21st June, 2022

Pedanius Therapeutics to present at Hamburg workshop on "Molecular Basis of Antibiotic Permeability in Gram-negative Bacteria"

Read on

18th November, 2020

Pedanius Therapeutics supporting World Antimicrobial Resistance Awareness Week 2020

Read on

26th February, 2021

Pedanius Therapeutics to present at OBN (UK) BioTuesday session on "How disruptive will RNA Technology be in Discovery and Development of Vaccines and Novel Therapies?"

Read on

9th June 2020

Pedanius Therapeutics attending the BIO Digital 2020 International Convention

Read on

28th April 2020

Pedanius Therapeutics attending the BioTrinity 2020 Life Sciences Conference

Read on

7th February, 2020

Pedanius Therapeutics to present at the 2020 BioInfect Conference

Read on

27th January, 2020

Pedanius Therapeutics LepB, RpsJ and LptD programmes demonstrates in vivo efficacy in Pneumonia caused by P. aeruginosa

Read on

10th January 2020

TheraIndx Lifesciences successfully delivers in vivo Pharmacology for Pedanius Therapeutics SBRI Contract to Tackle Antimicrobial Resistance in Humans 

Read on

28th November, 2019

Pedanius Therapeutics announces filing of an International PCT patent application relating to new bacterial RNA-targeted therapeutics

Read on

14th March, 2019

Pedanius Therapeutics presents at 

12th Berlin Conference on Life Sciences Novel Antimicrobials and AMR Diagnostics 2019

Read on

13th December, 2019

Pedanius Therapeutics FtsZ programme demonstrates in vivo efficacy in Pneumonia caused by A. baumannii

Read on

28th June, 2019

Key Organics successfully delivers Chemistry for Pedanius Therapeutics SBRI Contract to Tackle Antimicrobial Resistance in Humans 

Read on

22nd February, 2019

Pedanius Therapeutics secures £499,532 SBRI Contract to Tackle Antimicrobial Resistance in Humans

.

Read on

6th December, 2019

Pedanius Therapeutics AcpP programme demonstrates in vivo efficacy in UTI caused by E. coli

Read on

29th March, 2019

Pedanius Therapeutics announces a NBIC funded research collaboration with the University of Nottingham to tackle biofilms

Read on

16th February, 2019

Pedanius Therapeutics announces filing of a patent application relating to new bacterial RNA-targeted therapeutics

Read on